文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

静脉-静脉体外膜氧合中的出血、血栓栓塞与临床结局

Bleeding, Thromboembolism, and Clinical Outcomes in Venovenous Extracorporeal Membrane Oxygenation.
PubMed 文献 · Crit Care Explor · 2020-11-09
一句话结论VV-ECMO抗凝患者中出血(45.5%)远比血栓栓塞(14.5%)常见,且出血与更长的ECMO支持时间和更差的院内生存相关。

这项单中心回顾性队列研究纳入55例接受VV-ECMO并抗凝的成人患者,排除ECMO前活动性出血或血栓、7天内创伤或手术、动脉插管及外院ECMO>48小时者。结果显示出血事件25例(45.5%),血栓栓塞8例(14.5%);出血与ECMO支持时间延长(p=0.007)和院内生存更差(p=0.02)相关,而血栓栓塞未见与临床结局相关。作者结论认为出血较血栓栓塞更常见且与生存恶化相关,提示需要随机试验评估VV-ECMO持续静脉抗凝的安全性和有效性。

要点

  • 55例VV-ECMO抗凝成人中出血25例(45.5%),血栓栓塞8例(14.5%),出血约为血栓栓塞的3倍。
  • 出血事件与ECMO支持时间更长相关(p=0.007),并与更差院内生存相关(p=0.02)。
  • 血栓栓塞事件未显示与临床结局相关。
  • 该队列排除ECMO前活动性出血/血栓、7天内创伤或手术、动脉插管及外院ECMO>48小时者,结论外推需谨慎。
  • 原文未提及具体抗凝药物、剂量或目标值。

适用人群与场景

  • 接受VV-ECMO并抗凝的成人患者,单中心学术医疗中心。
  • 排除ECMO启动前有活动性出血或血栓栓塞、ECMO启动前7天内有创伤或手术史、使用动脉ECMO插管、或在其他机构接受ECMO支持>48小时的患者。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:单中心回顾性队列研究,样本量55例,无干预(观察性)。
  • 主要结局:出血事件25例(45.5%),血栓栓塞事件8例(14.5%)。
  • 出血事件与ECMO支持时间延长相关(p=0.007),与更差院内生存相关(p=0.02)。
  • 血栓栓塞事件未显示与临床结局相关。

证据类型、等级与局限

  • 证据类型:单中心回顾性队列研究;原文未给出证据等级或推荐强度。
  • 局限:回顾性设计、单中心、样本量小(55例)、无随机对照,原文未提及具体抗凝方案细节。

对床旁实践的改变

  • 提示VV-ECMO抗凝管理中出血比血栓栓塞更常见且与更差生存相关,床旁应重视出血监测与处理。
  • 原文未提供具体抗凝药物、剂量或目标值,不能据此改变具体抗凝方案。
  • 适用人群为符合该队列入选标准的VV-ECMO成人患者;ECMO前活动性出血/血栓、近期创伤或手术、动脉插管及外院ECMO>48小时者不适用。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Bleeding and thromboembolism are common during venovenous extracorporeal membrane oxygenation. The relative frequency of these complications and their impact on clinical outcomes have not been described, and no randomized trials exist to guide anticoagulation strategies in extracorporeal membrane oxygenation. Our objective was to examine the relative frequencies of bleeding and thromboembolic events and their associations with survival among a cohort of consecutive patients receiving venovenous extracorporeal membrane oxygenation.

DESIGN: Retrospective cohort study.

SETTING: A single academic medical center.

PATIENTS: Adult patients receiving venovenous extracorporeal membrane oxygenation and anticoagulation. Eligibility criteria for this analysis were selected to emulate the population that would be recruited for a randomized trial of anticoagulation strategies during venovenous extracorporeal membrane oxygenation. Patients were excluded if they had active bleeding or thromboembolism prior to extracorporeal membrane oxygenation initiation, a history of trauma or surgery in the 7 days prior to extracorporeal membrane oxygenation initiation, an arterial extracorporeal membrane oxygenation cannula, or if they received greater than 48 hours of extracorporeal membrane oxygenation support at another institution.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Outcomes included bleeding and thromboembolic events, duration of extracorporeal membrane oxygenation support, hospital length of stay, and in-hospital survival among 55 patients receiving venovenous extracorporeal membrane oxygenation. Bleeding events occurred in 25 patients (45.5%), and thromboembolism occurred in eight patients (14.5%). Bleeding events were associated with longer duration of extracorporeal membrane oxygenation support (p = 0.007) and worse in-hospital survival (p = 0.02). Thromboembolic events did not appear to be associated with clinical outcomes.

CONCLUSIONS: In this cohort of patients receiving venovenous extracorporeal membrane oxygenation and anticoagulation, bleeding occurred more frequently than thromboembolism and was associated with worse survival. These results highlight the need for randomized trials to evaluate the safety and efficacy of continuous IV anticoagulation among patients receiving venovenous extracorporeal membrane oxygenation.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Stokes JW, Gannon WD, Sherrill WH, et al. Bleeding, Thromboembolism, and Clinical Outcomes in Venovenous Extracorporeal Membrane Oxygenation. Crit Care Explor. 2020. PMID: 33196049. doi:10.1097/CCE.0000000000000267

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。